Archive for February, 2010
(AZN) AstraZeneca Sees Label Expansion for Crestor
AstraZeneca (AZN) received approval from the US Food and Drug Administration (FDA) for expanded use of one of its key drugs, Crestor (rosuvastatin calcium). The drug can be used to treat patients with normal cholesterol levels but with increased risk of cardiovascular disease. In...
9Feb2010 | vitalstocks | 0 comments | Continued(CUZ) Cousins Properties’ Funds From Operations Plummets
Cousins Properties Inc. (CUZ), a real estate investment trust (REIT), reported dismal fourth quarter 2009 results, with FFO (fund from operations) of $7.3 million or 7 cents per share, compared to $10.2 million or 20 cents per share in the year-earlier quarter. Fund from operations,...
9Feb2010 | vitalstocks | 0 comments | Continued(AGNC) American Capital Agency Corporation’s Earnings Surge
American Capital Agency Corp. (AGNC), a real estate investment trust (REIT) that focuses on investments in mortgage pass-through securities and collateralized mortgage obligations (CMOs), reported strong fourth quarter 2009 results despite challenging market conditions. The company...
9Feb2010 | vitalstocks | 0 comments | Continued(BJS) BJ Services Company Reports Loss Against Expected Profit
BJ Services Company (BJS) reported its fiscal first quarter (ended December 31, 2009) loss of 3 cents per share, compared to the Zacks Consensus Estimate of a profit of 5 cents and year-earlier quarter earnings of 56 cents. Revenue for the quarter decreased 34% year-over-year...
9Feb2010 | vitalstocks | 0 comments | Continued(TMRK) Terremark Worldwide’s Loss Exceeds Estimates
Terremark Worldwide (TMRK), a leading global provider of IT infrastructure solutions, announced results for the third quarter of fiscal 2010 with a loss per share of 13 cents exceeding the Zacks Consensus Estimate of loss of 8 cents. Net loss of $8.3 million for the quarter,...
9Feb2010 | vitalstocks | 0 comments | Continued(AMGN) Amgen Earns Positive Results From Phase III Drug Study
Amgen Inc. (AMGN) received a boost recently when the company announced positive results from a pivotal head-to-head phase III study that was conducted with Amgen’s main pipeline candidate, denosumab. The study compared denosumab with Novartis’ (NVS) Zometa in the treatment...
9Feb2010 | vitalstocks | 0 comments | Continued(ERTS) Electronic Arts’ Net Earnings Report Falls
Electronic Arts Inc. (ERTS) reported third-quarter of 2010 results with a steep fall in net earnings and revenue due to weakness in its EA business, dismal holiday sales for the overall packaged goods sector in Europe and product mix shifts to lower-margin distribution business...
9Feb2010 | vitalstocks | 0 comments | Continued(BA) Boeing Progressing on 747-8 Cargo Aircraft
Boeing Company (BA) successfully completed the first test flight of its long-in-the-making 747-8 Freighter. The 747-8 Freighter is the new, high-capacity 747 that brings the benefits of low operating costs and best economics in any freighter to cargo operators. The 747-8 is powered...
9Feb2010 | vitalstocks | 0 comments | Continued(TWC) Switched Digital Video is Thriving
The Switched Digital Video (SDV) technology is likely to boom in near future as more and more large cable MSOs in the U.S. are gradually moving towards overall services convergence. SDV technology distributes digital video content through cable network in a cost-effective manner...
9Feb2010 | vitalstocks | 0 comments | Continued(SASR) Small Bank Stocks Are Hot
As always I start my quest for the next great stock by taking the new high list on Barchart and sorting for frequency. I then take the top 10 and look for something interesting. Yesterday when all the major banks were getting hit on the chin the smaller and regional banks...
9Feb2010 | Shawn | 0 comments | Continued(ONNN) ON Semiconductor Looks Good
ON Semiconductor (ONNN) reported fourth quarter earnings that beat the Zacks Consensus estimate by 4 cents. Revenue Revenue of $497.1 million was up 5.1% sequentially and down 1.7% year over year. This was better than management’s revenue expectations of 480-495 million (up...
8Feb2010 | vitalstocks | 0 comments | Continued(SLGN) Silgan Holdings Incorporated Outperforms
Silgan Holdings Inc. (SLGN) reported its fourth-quarter earnings last week. The company posted earnings of 63 cents per share, beating the Zacks Consensus Estimate of 54 cents and up 40.0% from the year-ago earnings of 45 cents per share. Net sales in the quarter declined 4.9%...
8Feb2010 | vitalstocks | 0 comments | Continued(TM) Toyota Motor’s Prius Faces Recall
Toyota Motor’s (TM) popular 2010 Prius hybrid automobile faces a recall, adding to the series of the automaker’s recalls in the past few months. Toyota will decide upon the magnitude of the recall this week. In September last year, Toyota recalled the largest-ever U.S. batch...
8Feb2010 | vitalstocks | 0 comments | Continued(LMNX) Luminex Corporation’s Revenues Expand
Luminex Corp. (LMNX) reported fourth-quarter fiscal 2009 earnings (excluding the release of the valuation allowance) of $5.2 million or 12 cents per share, up from $2 million or 5 cents per share in the year-ago quarter. The Zacks Consensus Estimate for the reported quarter was...
8Feb2010 | vitalstocks | 0 comments | Continued(NDN) 99 Cents Only Stores Easily Beats Estimates
99 Cents Only Stores Inc. (NDN) recently reported its fiscal 2010 third quarter results. The company recorded a strong 97% growth in earnings to $24.5 million from $12.4 million in the year-ago period. Earnings per share came in at 35 cents, easily beating the Zacks Consensus...
8Feb2010 | vitalstocks | 0 comments | Continued(BG) Bunge Limited Wraps Up Initial Moema Deal
Bunge Ltd. (BG), a leading global agribusiness and food company in the U.S., has recently completed the first phase of 100% acquisition of Usina Moema Participacoes S.A., a holding company that wholly owns one sugarcane mill in Brazil and has ownership interests in five others. With...
8Feb2010 | vitalstocks | 0 comments | Continued($M) Macy’s Incorporated Raises Outlook
Macy’s Inc. (M) raised its earnings guidance for the fourth quarter and fiscal 2009, buoyed by better-than-expected sales and effective cost management. Macy’s now expects fourth-quarter earnings in the range of $1.35 to $1.37 per share, up from its prior view of $1.14 to...
8Feb2010 | vitalstocks | 0 comments | Continued(NHP) Nationwide Health Properties Acquires Two Properties
Nationwide Health Properties, Inc. (NHP), a real estate investment trust (REIT) that invests in healthcare facilities, recently acquired 2 medical office buildings (MOB) from Pacific Medical Buildings LLC. Pacific Medical specializes exclusively in the development and management...
8Feb2010 | vitalstocks | 0 comments | Continued(FII) Federated Investors Incorporated Initiated as Neutral
We are initiating coverage on Federated Investors Inc. (FII) with a Neutral recommendation. The company’s fourth-quarter earnings of 51 cents per share missed the Zacks Consensus Estimate by a couple of pennies on money fee waivers and higher operating expenses. Results reflected...
8Feb2010 | vitalstocks | 0 comments | Continued(NTT) Nippon Telegraph & Telephone Corporation Outperforms Expectations
Nippon Telegraph & Telephone Corp. (NTT) declared better-than-expected fiscal third quarter 2010 financial results. On a GAAP basis, net income in the third quarter of fiscal 2010 was approximately $1,523 million or $1.15 per share, compared to net income of approximately...
8Feb2010 | vitalstocks | 0 comments | Continued(AXL) American Axle and Manufacturing Swings to Profit
American Axle and Manufacturing (AXL) returned to profitability in the fourth quarter of 2009 after reporting losses since the first quarter of 2008. The company has posted a net income of $8.3 million or 14 cents per share (before special items), compared to a loss of $42.6...
8Feb2010 | vitalstocks | 0 comments | Continued(MMP) Magellan Midstream Partners L.P.’s Net Income Rises
Magellan Midstream Partners L.P. (MMP), a master limited partnership (MLP), announced robust fourth quarter results, buoyed by higher transportation tariffs and product gains in the pipeline system. The partnership reported earnings per unit (EPU) of 77 cents, surpassing the...
8Feb2010 | vitalstocks | 0 comments | Continued(AMCC) Top-Line Increases at AppliedMicro
AppliedMicro (AMCC) reported revenues of $53.7 million in the third quarter of fiscal 2010, up 9% sequentially and up 13% year over year. Product revenues increased 10% sequentially. Processor revenues were $28.0 million, up sequentially. Transport revenues were $22.7 million,...
8Feb2010 | vitalstocks | 0 comments | Continued(MCRS) MICROS Systems Beats Estimates
MICROS Systems, Inc. (MCRS) reported revenues of $225.6 million in the second quarter of fiscal 2010, down 4.6% from a year ago but almost flat sequentially. On a segment basis, hardware revenues came in at $45.8 million, down 17.7% year over year. Software revenues came in at...
8Feb2010 | vitalstocks | 0 comments | Continued(SII) Smith International Plans Acquisitions
Smith International Inc. (SII), a major oilfield services company, expects to spend approximately $350 million on acquisitions in this quarter, following the company’s last year’s $700 million-plus stock issue. In addition to acquisition initiatives, the company also intends...
8Feb2010 | vitalstocks | 0 comments | Continued(EWJ) Investing in Japan: Two Ways to Play Its Stock Market Revival
by Alexander Green, Chief Investment Strategist Monday, February 8, 2010: Issue #1192 Here’s a handy way to know when to sell your investments: everyone is talking about them. There is an obvious corollary to knowing what to sell. If you want to know what to buy, consider...
8Feb2010 | InvestmentU | 0 comments | Continued(LIFE) Life Technologies Corporation Sells Mass Spectrometry Business
Life Technologies Corporation (LIFE) recently completed the sale of its mass spectrometry business to Danaher Corporation (DHR) for $450 million in cash, subject to a conventional working capital adjustment. Danaher also acquired Life’s joint venture partner in the mass spectrometry...
8Feb2010 | vitalstocks | 0 comments | Continued(MRK) Merck & Company Earns EU Approval For Elonva
Recently, Merck & Co. Inc. (MRK) received approval from the European Commission (EC) for its fertility drug Elonva (corifollitropin alfa injection). The drug will be used as a treatment in controlled ovarian stimulation (COS) coupled with a GnRH antagonist for the development...
8Feb2010 | vitalstocks | 0 comments | Continued(L) Loews Corporation Reports Shy of Expectations
Loews Corporation’s (L) fourth quarter income from continuing operations came in at 94 cents per share, 2 cents below the Zacks Consensus Estimate of 96 cents. However, the results were significantly better compared to the year-ago quarter’s results when the company had reported...
8Feb2010 | vitalstocks | 0 comments | Continued(NVTL) Novatel Wireless Gets Downgraded
We downgrade our recommendation for Novatel Wireless Inc. (NVTL) to Neutral, which means the stock should perform in line with the broader market. The company is facing intensifying competition for its core embedded solutions for wireless access. In addition to its traditional...
8Feb2010 | vitalstocks | 0 comments | Continued